Dr. Reddy's Lab spikes on launch of Hydroxychloroquine Sulfate Tablets in US Dr. Reddy's Lab spikes on launch of Hydroxychloroquine Sulfate Tablets in US Sanket Dewarkar / Thursday, July 12, 2018 0 1870 Article rating: 4.0 Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets USP, 200 mg, a generic version of Plaquenil Tablets, in the US market. The drug was earlier approved by the US Food and Drug Administration (USFDA). Read more
L&T Construction bags Rs. 2,388 crore order L&T Construction bags Rs. 2,388 crore order Gayathri Udyawar / Thursday, July 12, 2018 0 1321 Article rating: 5.0 Diversified company L&T's construction arm has received two Water & Effluent Treatment orders from Madhya Pradesh corporation and Tirunelveli Municipal Corporation. Read more
The Market Conundrum The Market Conundrum Shashikant Singh / Thursday, July 12, 2018 0 1475 Article rating: 5.0 Equity bellwether indices touched their lifetime highs, but the broader markets refused to join the party and are yet to recover. Read more
Alembic Pharma receives tentative USFDA approval for Ticagrelor Tablets Alembic Pharma receives tentative USFDA approval for Ticagrelor Tablets Shohini Nath / Thursday, July 12, 2018 0 2379 Article rating: 5.0 Alembic Pharmaceuticals has informed that the company has received tentative approval for its abbreviated new drug Ticagrelor Tablets, 90 mg. Read more
Acquisition of Mirren to help Cipla strengthen OTC segment Acquisition of Mirren to help Cipla strengthen OTC segment Amir Shaikh / Thursday, July 12, 2018 0 1389 Article rating: 5.0 The company stated that this acquisition will help Cipla gain market share and grow in OTC segment. The expected time for completion of this transaction is September 201 Read more